Is HER2-positive metastatic breast cancer curable?
Metastatic (stage 4) HER2-positive breast cancer is not curable—but it is treatable, and options continue to expand and improve.
Is HER2 metastatic breast cancer?
About 20% of breast cancers are HER2-positive. They usually grow quicker than other types of cancer. Metastatic HER2-positive breast cancer has spread beyond the breast to other parts of the body.
What is the best treatment for HER2-positive metastatic breast cancer?
The combination of lapatinib and the chemotherapy capecitabine is approved to treat metastatic HER2-positive breast cancer when a patient has already received chemotherapy and trastuzumab. The combination of lapatinib and letrozole is also approved for metastatic HER2-positive and ER-positive cancer.
Do you have to have chemo if you are HER2-positive?
Because HER2-positive cancer is considered more aggressive than HER2-negative breast cancer, it is usually treated with chemotherapy after surgery to reduce recurrence risk.
What is the life expectancy for Stage 2 breast cancer?
According to the American Cancer Society, the five-year survival rate for stage 2 breast cancer is 93% for women who have completed treatment. Women with stage 3 cancer have a five-year survival rate of 72%.
What you should know about HER2+ breast cancer survival rates?
Survival rates for HER2+ breast cancers can vary by subtype: The 5-year relative survival of patients with HR+/HER2+ breast cancers is 90.4%, the second-best survival of all women with breast cancer. 1. Although this subtype is the least common, the 5-year relative survival of patients with HR-/HER2+ breast cancers is 83.6%. 1.
Is HER2 negative breast cancer curable?
Triple-negative breast cancers are negative for HER2, estrogen, and progesterone, while triple-positive breast cancers are positive for all three. If you have triple negative or HER2-negative breast cancer, many commonly used therapies may not help your disease.
What is the latest treatment for metastatic breast cancer?
Chemotherapy